89bio, Inc.
ETNBDelisted Oct 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785173
89bio, Inc. was delisted on Oct 30, 2025; its insiders filed their last Form 4 on Nov 3, 2025; 198 institutions reported holding it in 13F filings for Q3 2025, worth $2.27B in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding 89bio, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 48 | 50 | +2 |
| Shares | 17.3M | 17.3M | −16.8K (−0.1%) |
| Value | $339.4M | $226.1M | −$113.3M (−33.4%) |
New holders (7)
Institutions that held 89bio, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Altium Capital Management LP | 148,000 | $1.93M | 0.54% |
| Trexquant Investment LP | 13,408 | $175.0K | 0.01% |
| Goldman Sachs Group Inc | 10,245 | $134.0K | 0.00% |
| Wells Fargo & Company | 3,652 | $48.0K | 0.00% |
| Aquatic Capital Management LLC | 2,600 | $34.0K | 0.07% |
| Toronto Dominion Bank | 1 | $0 | 0.00% |
| Federated Hermes, Inc. | 12 | – | – |
Sold out (5)
Institutions that held 89bio, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Alyeska Investment Group, L.P. | 51,705 | $1.01M |
| Virtus ETF Advisers LLC | 10,877 | $213.0K |
| SG Americas Securities, LLC | 5,661 | $111.0K |
| Simplex Trading, LLC | 3,481 | $64.0K |
| Ellevest, Inc. | 3 | $0 |